We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
-8.99%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$798M
AUM Growth
-$110M
Cap. Flow
-$2.61M
Cap. Flow %
-0.33%
Top 10 Hldgs %
29.72%
Holding
97
New
9
Increased
24
Reduced
42
Closed
4

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$26.5M
2
MRK icon
Merck
MRK
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$11.7M
4
NKTR icon
Nektar Therapeutics
NKTR
+$11.6M
5
ESPR
Esperion Therapeutics
ESPR
+$9.66M

Top Sells

Rank Stock Value
1
HBNC icon
Horizon Bancorp
HBNC
+$26.2M
2
HUM icon
Humana
HUM
+$12.6M
3
INCY icon
Incyte
INCY
+$8.5M
4
ELV icon
Elevance Health
ELV
+$8.22M
5
HCA icon
HCA Healthcare
HCA
+$7.9M

Sector Composition

Rank Sector Weight
1 Healthcare 92.7%
2 Industrials 0.42%
3 Technology 0.13%
4 Financials 0.1%
5 Energy 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VKTX icon
76
Viking Therapeutics
VKTX
$4B
$1.38M 0.17%
200,000
-91,499
-31% -$680K
PVLA
77
Palvella Therapeutics
PVLA
$2.24B
$1.02M 0.13%
3,750
– –
ACHN
78
DELISTED
Achillion Pharmaceuticals
ACHN
$1M 0.13%
277,800
– –
ADVM
79
DELISTED
Adverum Biotechnologies
ADVM
$652K 0.08%
11,967
– –
CVX icon
80
Chevron
CVX
$375B
$353K 0.04%
2,974
– –
BUD icon
81
AB InBev
BUD
$163B
$324K 0.04%
3,409
– –
IBM icon
82
IBM
IBM
$224B
$322K 0.04%
2,317
– –
JPM icon
83
JPMorgan Chase
JPM
$953B
$291K 0.04%
2,472
– –
XOM icon
84
ExxonMobil
XOM
$653B
$272K 0.03%
3,854
– –
VIRX
85
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$272K 0.03%
10,778
– –
DIS icon
86
Walt Disney
DIS
$179B
$271K 0.03%
2,083
– –
F icon
87
Ford
F
$55B
$267K 0.03%
29,164
– –
WFC icon
88
Wells Fargo
WFC
$264B
$266K 0.03%
5,272
– –
QCOM icon
89
Qualcomm
QCOM
$175B
$259K 0.03%
3,391
– –
JHG
90
DELISTED
Janus Henderson
JHG
$239K 0.03%
10,645
– –
MSFT icon
91
Microsoft
MSFT
$3.76T
$213K 0.03%
1,532
– –
GEN icon
92
Gen Digital
GEN
$17.5B
$207K 0.03%
+8,761
New +$204K
HBNC icon
93
Horizon Bancorp
HBNC
$1.04B
– –
-1,087,656
Closed -$26.2M
INCY icon
94
Incyte
INCY
$24.7B
– –
-100,000
Closed -$8.5M
QGEN icon
95
Qiagen
QGEN
$9.01B
– –
-56,583
Closed -$2.44M
ONCE
96
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-10,000
Closed -$1.02M
1 2 3
4

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Rhenman & Partners Asset Management held 97 positions worth $798M, down 12% from $908M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rhenman & Partners Asset Management's Q3 2019 filing shows 9 new, 24 increased, 42 reduced and 4 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,025,000 shares worth $27.9M. The largest sale was Horizon Bancorp, an estimated $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 91% a quarter earlier, followed by Industrials and Technology.

  • Rhenman & Partners Asset Management's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,025,000 shares worth $27.9M.
  • Rhenman & Partners Asset Management added most to Nektar Therapeutics in Q3 2019, an estimated $11.6M increase.
  • Rhenman & Partners Asset Management's biggest Q3 2019 reduction was Humana, cutting an estimated $12.6M.
  • Rhenman & Partners Asset Management fully exited Horizon Bancorp in Q3 2019, selling an estimated $26.2M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 30% of its $798M portfolio in Q3 2019.
  • Rhenman & Partners Asset Management opened 9 new positions and closed 4 in Q3 2019.
  • Rhenman & Partners Asset Management's portfolio value fell 12% quarter-over-quarter to $798M.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2019, filed 16 Oct 2019.